GSK plans
October 14, 2009Research and Development GSK
GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …
Merck makes Indian bioscience acquisition
October 14, 2009Research and Development Asia, India, Merck
Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …
Hospira takes charge of biogeneric Neupogen
October 14, 2009Sales and Marketing Hospira, biosimilars, generics
US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …
GSK’s Avodart tackles BPH better in combination
October 14, 2009Research and Development, Sales and Marketing GSK, bph, urology
GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …
Green light at Angelini plant resurrects antidepressant prospects
October 13, 2009Manufacturing and Production Angelini
Canadian drugmaker Labopharm has been boosted by the news that manufacturing problems holding up approval of its novel antidepressant product, …
Oakley launches Oxygen Health
October 13, 2009Medical Communications Oxygen, PR, hc
Oxygen Health, an agency aiming to help pharma companies communicate more effectively with stakeholders, has launched.It has been set up …
Contract research news in brief
October 13, 2009Research and Development CRO
Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …
GSK expands in China with vaccine joint venture
October 12, 2009Sales and Marketing China, GSK, vaccines
GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …
FDA revises cancer vaccine guidance
October 12, 2009Sales and Marketing Cancer, US, reg, vacccine
There are concerns that draft guidance from the US Food and Drug Administration, which will recommend that cancer vaccine trials …
Personal health budget pilots to be assessed
October 12, 2009Sales and Marketing NHS, hc
The success or otherwise of personal health budgets is to be assessed in a study on their benefits across 20 …
Digital Pharma: GSK pushes patient information boundaries
October 12, 2009Medical Communications GSK, digi, digital pharma, patient information
GlaxoSmithKline has launched a product information website for patients in the UK, becoming the second major pharma company to push …
Montreal gets manufacturing boost from Schering-Plough
October 9, 2009Manufacturing and Production Canada, Merck
Schering-Plough says it is planning to invest more than C$30 million ($28 million) to expand a pharmaceutical manufacturing facility in …
Head-to-head trial favours Shire’s Fosrenol
October 8, 2009Research and Development, Sales and Marketing fosrenol, renal
Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …
Simponi approved in Europe
October 8, 2009Sales and Marketing RA, Simponi, TNF
Rheumatic disease drug Simponi has received marketing approval for Europe, where it will be marketed by Schering-Plough.The drug is indicated …
Paying their own way: pharma and doctors to share CME costs
October 8, 2009Medical Communications CME
The UK could be heading for a major overhaul of its Continued Medical Education (CME), as pharma and doctors look …
Reshuffle at Rexam creates healthcare unit
October 7, 2009Manufacturing and Production Rexam, packaging
Packaging giant Rexam is merging three of its units into one global healthcare division headed by former Rexam Pharma chief …
GSK agrees more government orders for H1N1 vaccine
October 7, 2009Sales and Marketing GSK, h1n1, vaccines
GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …
European pharma companies raided
October 7, 2009Sales and Marketing EU, reg
Several pharma companies have been raided as part of ongoing European Commission investigations into competitiveness issues. Sanofi-Aventis, Novartis and generic …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
